MGC Derma Ups Ante In 'Green' Skin Care With Cannabis-Based Debut
This article was originally published in The Rose Sheet
Executive Summary
The 14-product Ananda CBD Cosmetics line features a non-psychoactive cannabis extract with powerful antioxidant, anti-aging, anti-inflammatory and analgesic properties, according to the personal-care division of Australia-based MGC Pharmaceuticals. Meanwhile, the company is in clinical trials with an eye toward marketing OTC drugs that treat acne, psoriasis and seborrheic dermatitis.
You may also be interested in...
The Honest Company Now Defending 'Natural' Claims On Both Coasts
Already embroiled in litigation in California, Honest now faces a proposed class action in New York citing a laundry list of chemicals and at least 40 of its personal-care and household products as evidence of false "natural" advertising and other violations. The legal woes could complicate a valuation of the company as it reportedly is exploring an initial public offering.
Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat
Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.
L’Oreal Joins J&J And Major Retailers Defending Benzene Class Actions In Federal Courts
Benzoyl peroxide-based acne drug products and their alleged proclivity to become contaminated with carcinogenic benzene are at the center of putative class actions filing against L’Oreal in federal courts around the US.